Leadership Overview
Ascendis Health has 4 executives leading key functions including strategy, operations, finance, and supply chain.
Driven by a commitment to health and wellness, Ascendis Health focuses on delivering innovative solutions that enhance quality of life across South Africa and beyond.
Driven by a commitment to health and wellness, Ascendis Health focuses on delivering innovative solutions that enhance quality of life across South Africa and beyond.
Leadership Roles at Ascendis Health
Carl Neethling - Chief Executive Officer
Carl Neethling, the Chief Executive Officer at Ascendis Health, directs the company's overall strategic vision and operational execution. Neethling guides Ascendis Health's expansion initiatives, ensuring alignment with market demands in the health and wellness sector. The Chief Executive Officer oversees critical business development functions, fostering partnerships that drive sustainable growth and enhance the company's market presence. This leadership position involves managing key stakeholder relationships and ensuring the company's financial health and long-term viability. Carl Neethling's strategic direction is pivotal in navigating the competitive landscape of the pharmaceutical manufacturing industry, focusing on innovation and operational excellence to meet consumer needs. The Chief Executive Officer's responsibilities extend to championing the company's mission of improving lives through accessible health solutions.
Lihle Mbele - Chief Financial Officer
Lihle Mbele, the Chief Financial Officer at Ascendis Health, directs all financial planning, management, and reporting activities. Mbele oversees the company's fiscal health, managing budgets, investments, and financial risk to ensure stability and profitability. The Chief Financial Officer's responsibilities include developing financial strategies that support Ascendis Health's long-term objectives and expansion plans. This critical role involves ensuring compliance with financial regulations and optimizing capital allocation across various business units. Lihle Mbele provides essential financial insights to guide strategic decision-making, driving initiatives that enhance shareholder value and operational efficiency. The Chief Financial Officer's expertise is fundamental to maintaining the financial integrity and sustainable growth of the organization within the pharmaceutical sector.
Piet van Zyl - Chief Operating Officer
Piet van Zyl, the Chief Operating Officer at Ascendis Health, manages the day-to-day operational activities and optimizes internal processes. Van Zyl oversees the efficient functioning of manufacturing, logistics, and supply chain operations, ensuring product availability and quality standards are consistently met. The Chief Operating Officer's role involves implementing operational strategies that support the company's growth objectives and enhance overall efficiency. This leadership function is critical for maintaining the integrity of Ascendis Health's product delivery systems across South Africa. Piet van Zyl drives initiatives aimed at improving operational performance, reducing costs, and ensuring seamless integration of new technologies within the production environment. The Chief Operating Officer's focus remains on strengthening the company's operational backbone to support its health and wellness mission.
Dr Fadal - Chief Operations Officer
Dr Fadal, the Chief Operations Officer at Ascendis Health, spearheads the strategic oversight of production and operational excellence. Fadal focuses on enhancing manufacturing capabilities and streamlining supply chain logistics to meet the growing demand for health and wellness products. The Chief Operations Officer's mandate includes driving innovation in operational processes and ensuring the highest standards of quality control across all production facilities. This leadership position is vital for maintaining Ascendis Health's competitive edge in the pharmaceutical industry. Dr Fadal's strategic initiatives aim to optimize resource utilization and foster a culture of continuous improvement within the operations division. The Chief Operations Officer's commitment is to ensure the efficient and effective delivery of Ascendis Health's product portfolio.
Explore Leadership Teams in Manufacturing
Amrutanjan Health Care Ltd specializes in pain and congestion management products, including aromatic balms, roll-ons, and sprays. Founded in 1893, the company is dedicated to enhancing people's well-being by combining natural extracts with scientific research to create effective, side-effect-free solutions. Their product range caters to various needs, including headache relief, body pain management, and women's hygiene. Amrutanjan aims to serve a global consumer base while maintaining a commitment to sustainability and social responsibility.
Company Leadership PD
MB
JC
Jamjoom Pharma is one of the leading pharmaceutical companies in the Afrasia region focused on the Middle East, Africa, and CIS countries. Based in Jeddah, Saudi Arabia, Jamjoom Pharma manufactures and markets pharmaceutical products, over the counter (OTC) medicines, and health related consumer products. The company is owned by the Jamjoom Group.
Company Leadership NS
TH
AM
AH
Shionogi & Co., Ltd. is a Japanese pharmaceutical company dedicated to developing innovative treatments that improve patient lives worldwide. With a longstanding focus on addressing pressing global health challenges, the company has been a pioneer in discovering and delivering novel therapies for infectious diseases, including antibiotics, HIV, influenza, and emerging viral threats such as COVID-19. Shionogi combines in-house research and development with strategic collaborations across industry, government agencies, biotech companies, and academic institutions to accelerate the advancement of its scientific programs and bring meaningful therapies to patients with urgency and precision.
Company Leadership TK

TN
MF
Alkermes plc is a global biopharmaceutical enterprise that specialises in developing and commercialising innovative medicines for people living with complex psychiatric and neurological disorders. Headquartered in Dublin, Ireland, the company combines deep neuroscience expertise with patient‑inspired science to pursue treatments for conditions such as addiction, schizophrenia, bipolar disorder, opioid dependence and other central nervous system diseases. Its approach integrates scientific research, clinical development and specialised commercial infrastructure to deliver both marketed medicines and investigational candidates, aiming to address serious unmet medical needs and improve how chronic neurological and mental health conditions are managed.
Company Leadership SS


